Key points are not available for this paper at this time.
Despite rampant direct-to-consumer ads regarding “low T” in older men, the Food and Drug Administration has concluded that the available evidence does not support an indication for testosterone therapy for “age-related hypogonadism.”
Nguyen et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: